Fighting Antimicrobial Resistance with Genetics and Genomics

Fighting Antimicrobial Resistance with Genetics and Genomics

Identification: MSNJ1914
Issue: September-October 2019
Volume: Vol. 28/No. 5
Credits (Post Test and/or Evaluation Required)
Available until 10/31/2021
  • 1.30 - CH

Non-member: $20.00


Antimicrobial resistance remains on the rise as available antibiotics become less effective. Well the challenges persist, novel therapies are being developed using genetic/genomic technology. Understanding emerging therapies allows nurses to gain insight into mechanisms of resistance and the tools available to combat it.

Learning Outcome:
After completing this educational activity, the learner will be able to describe how advances in genetics and genomics have influenced the development of many emerging therapies for bacterial infections.

Learning Engagement Activity:
1. The United Nations General Assembly defined antimicrobial resistance as not only the greatest, but also "the most urgent global risk" as per the CDC. For further study about AMR, reference this CDC website: Centers for Disease Control and Prevention (CDC). (2018a). Antibiotic/Antimicrobial resistance (AR/AMR): United Nations (UN) General Assembly. Retrieved from

2. Discuss the importance of educating patients and families regarding the safety of vaccines in general and the benefit of vaccines in managing AMR, specifically.

Contact hours available until 10/31/2021.

Requirements for Successful Completion:

Complete the learning activity in its entirety and complete the online CNE evaluation.

Authors Conflict of Interest Disclosure:
The author(s), editor, editorial board, content reviewers, and education director reported no actual or potential conflict of interest in relation to this continuing nursing education article.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Information:
This session is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Academy of Medical-Surgical Nurses (AMSN).

Anthony J Jannetti, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Anthony J. Jannetti, Inc. is an approved provider of continuing nursing education by the California Board of Registered Nurses, Provider Number CEP 5387.

This article was reviewed and formatted for contact hour credit by Michelle Boyd, MSN, RN, AMSN Education Director.


Credits Available

Fighting Antimicrobial Resistance with Genetics and Genomics

You must be logged in and own this product in order to post comments.

Rynae Headid
12/18/19 12:23 pm

This article provides excellent information on developing treatment of AMR bacteria.

Constance Barnes
1/21/20 2:49 am

This was a great article. I learned many new things about how scientists are using genomic information to develop new antibiotics and potentially vaccines of diseases such as pneumonia and hopefully C-Diff.

Mokulongo Manzembe
5/17/20 4:11 pm

Very informative article. I Wasn't aware that research is being done for potential vaccine to treat antimicrobial resistance as alternative therapies to antibiotic treatment, e.g., C-diff and MRSA

Grace Allen
5/31/20 11:31 pm

Very interesting

Anal Rathod
9/1/20 11:14 pm

Great article. Learned novel therapies to combat antibiotics resistance bacteria. Thank you

Wendy Tsaninos
4/6/21 12:49 am

Fascinating what they are working on!

Anita Arguello
4/25/21 4:38 am

Excellent learning opportunity. Valuable information. It was great to see a through article on antibiotic stewardship and its future.

Eunice Sandoval
9/19/21 6:08 pm

Interesting article relating to creation of vaccines and the fight against antibiotic resistant microbes.